Pharma
CRA Insights: A landscape assessment of newborn screening (NBS) in Europe
Newborn screening (NBS) has become an integral part of many public health programs.1 NBS programs have minimized patient suffering which results from extended diagnostic pathways, as well as the irreversible damage to health due to late diagnosis. Furthermore, they have played a role in...
CONEXEN - Informal Networking in Cambridge - 17 April 2024
CONEXEN is a networking group for professionals working in the life sciences, biopharma, medical devices and health tech industries. Join us on April 17th Pre-registration is still open. ...
Milner Therapeutics Symposium 2024
Registration is now open for the Milner Therapeutics Symposium 2024! On 2nd July, a fantastic line-up of speakers will present live at West Road Concert Hall in Cambridge, with talks also streamed to an online platform. The Symposium is an opportunity for scientists from academia and in...
Transforming Healthcare Podcast: The importance of collaboration and cooperation in healthcare
In this episode, Dr Bipin Patel reunites with Tony Jones, Chief Executive of One Nucleus, a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. They support institutions, companies and individuals in the Life Sciences sector providing local,...
Webinar: Overcoming challenges in drug metabolism: in silico approaches
Interpreting metabolite-ID experiments; determining the right species for animal studies; providing optimisation suggestions for your medicinal chemistry colleagues to overcome metabolism issues – these are just a few of the challenging tasks assigned to DMPK scientists. How can we best...
SPT Labtech and RevoluGen demonstrate fully automated Bead-Based High Molecular Weight DNA Extraction
The collaboration delivers a walk-away solution suitable for high-throughput long-read sequencing in under two hours. ...
Challenges to a dual: What makes a dual-brand approach viable?
Pharmaceutical and biologic therapies are increasingly demonstrating their effectiveness in the treatment of multiple diseases. As the trend of therapies being studied and demonstrating effectiveness across multiple indications accelerates, manufacturers are pursuing different approache...
Optibrium launches a metabolism prediction software platform tailored to DMPK scientists
Semeta™ offers high sensitivity and superior precision for the prediction of Phase I and II metabolic routes, sites, products and liabilities in early drug discovery ...
The importance of ECD wipe tests for detector safety
Discover the significance of ECD wipe tests in ensuring detector safety and compliance with regulatory requirements. ...
Healthcare in UK and China, 2024 Trends, opportunities and challenges
Join us on 14 March to hear what industry insiders and experts discuss trends, market conditions, investment opportunities and restrictions, best practices and first-hand experience in the UK-China healthcare sector in 2024. What opportunities are available in the UK healthcare sector...